Author: Ravi Shankar

Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution

21. Oct 2026 / 18:01 CET/CEST, transmitted by GlobeNewswire.

The issuer is solely responsible for the content of this announcement.

---

Notification of Major Holdings

1. Details of issuer

2. Reason for notification

3. Details of person subject to the notification obligation

Natural Person

4. Name(s) of shareholder(s) holding directly 3% or more voting rights, if different from details of person subject to the notification obligation

5. Date on which threshold was crossed or reached

6. Total positions

7. Details on total positions

a. Voting rights attached to shares (Sec. 33, 34 WpHG)

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

8. Information in relation to the person subject to the notification obligation

9. In case of proxy voting according to Sec. 34 (3) WpHG

Date of general meeting

Total positions (6.) after general meeting:

10. Other useful information

Date

End of message

---

GlobeNewsWire Distribution Services include regulatory announcements, financial/corporate news and press releases.

Archive at www.globenewswire.com

---

Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution

21. Oct 2026 / 18:00 CET/CEST, transmitted by GlobeNewswire.

The issuer is solely responsible for the content of this announcement.

---

Notification of Major Holdings

1. Details of issuer

2. Reason for notification

3. Details of person subject to the notification obligation

Natural Person

4. Name(s) of shareholder(s) holding directly 3% or more voting rights, if different from details of person subject to the notification obligation

5. Date on which threshold was crossed or reached

6. Total positions

7. Details on total positions

a. Voting rights attached to shares (Sec. 33, 34 WpHG)

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

8. Information in relation to the person subject to the notification obligation

9. In case of proxy voting according to Sec. 34 (3) WpHG

Date of general meeting

Total positions (6.) after general meeting:

10. Other useful information

Date

End of message

---

GlobeNewsWire Distribution Services include regulatory announcements, financial/corporate news and press releases.

Archive at www.globenewswire.com

---

Aix-en-Provence, 21 October 2026 (6:00 p.m.)

HIGHCO: BUSINESS GROWTH IN Q3 2026 IN LINE WITH EXPECTATIONS, WITH REPORTED GROSS PROFIT OF €19.16 M (UP 22.5%) AND €15.88 M LFL (UP 1.6%); 2026 GUIDANCE REFINED

Rise in business activity in Q3 2026 still driven by France

• Q3 2026 gross profit¹ of €19.16 m on a reported basis (up 22.5% including Sogec and Budgetbox) and €15.88 m LFL² (up 1.6%).
• Nine-month YTD 2026 gross profit¹ of €58.37 m (up 25.3%) on a reported basis and €47.67 m LFL² (up 2.3%).
• Expected decline in the Retail Activation division over the quarter (Q3/reported 9-month YTD: up 16.7%/up 20.5%; Q3/LFL 9-month YTD: down 5.2%/stable), decline in Retail Agencies division businesses (Q3/9-month YTD: down 3.3%/down 0.1%) and increase, as expected, in the gross profit of the Retail Media division (Q3/reported 9-month YTD: up 87.6%/up 113.9%; Q3/LFL 9-month YTD: up 38.2%/up 22.3%).
• Business growth in France (Q3/reported 9-month YTD: up 27.2%/up 31.5%; Q3/LFL 9-month YTD: up 3.7%/up 5.3%) and decline in International business (Q3/9-month YTD: down 15.7%/down 18.7%).

EcoVadis Gold medal renewed

Refined guidance for 2026

• Gross profit of more than €77 m, for growth of more than 15% on a reported basis.
• Adjusted operating margin³ slightly higher than 13%.

Confirmation of a significant improvement in profitability as of 2027

• Adjusted operating margin³ expected at more than 15%.

Gross profit (in € M)	2026 Reported	2026 LFL2	2025	2026 Reported/2025 change	2026 LFL2/2025 change
Q1	19.93	16.18	15.77	+26.4%	+2.6%
Q2	19.29	15.61	15.19	+27.0%	+2.8%
Q31	19.16	15.88	15.63	+22.5%	+1.6%
9-month total1	58.37	47.67	46.59	+25.3%	+2.3%

1 Unaudited data.
2 Like for like: Based on a comparable scope (excluding acquisitions of Sogec and Budgetbox) and at constant exchange rates (i.e. applying the average exchange rate over the period to data from the compared period).
3 Adjusted headline profit before interest and tax (adjusted headline PBIT): Recurring operating income before restructuring costs and excluding the impact of performance share plans. Adjusted operating margin: Adjusted headline PBIT/Gross profit.

Didier Chabassieu, Chairman of the Management Board, stated, “HighCo posted a good third quarter, in line with our expectations and with gross profit up 1.6% like for like. This performance has enabled us to confirm our guidance for 2026 and maintain our forecasts for 2027 of a significant improvement in adjusted operating margin to more than 15%.”

RISE IN BUSINESS ACTIVITY IN Q3 2026 STILL DRIVEN BY FRANCE

In Q3 2026, HighCo posted gross profit of €19.16 m on a reported basis, for growth of 22.5%, including Sogec and Budgetbox, and €15.88 m like for like (up 1.6%) with:

• the expected slowdown over the quarter of the businesses in the Retail Activation division, which grew 16.7% to €11.40 m on a reported basis (down 5.2% like for like);
• decline in activities of the Retail Agencies division to €3.45 m (down 3.3%);
• growth in the Retail Media division of 87.6% to €4.3 m on a reported basis (up 38.2% like for like), in particular with the increase, as expected, in its core businesses of in-store media selling.

Over the first nine months of 2026 (up 25.3% reported; up 2.3% like for like), the Retail Activation division (63.3% of the Group’s reported gross profit including Sogec) showed growth of 20.5% on a reported basis and no change on a like-for-like basis, business in the Retail Agencies division (19% of the Group’s reported gross profit) remained virtually stable, down 0.1%, and the Retail Media division (17.7% of the Group’s reported gross profit including Budgetbox) grew 113.9% on a reported basis and 22.3% like for like.

Business growth in France

FRANCE	Gross Profit (€ m)			2026 Reported/2025 change	2026 LFL/2025 change	% Total gross profit Reported
	2026 Reported	2026 LFL	2025
Q1	18.18	14.43	13.58	+33.8%	+6.2%	91.2%
Q2	17.78	14.10	13.31	+33.6%	+6.0%	92.2%
Q3	17.71	14.44	13.92	+27.2%	+3.7%	92.5%
9-month total	53.67	42.97	40.81	+31.5%	+5.3%	92.0%

In France, reported gross profit totalled €17.71 m in Q3 2026 up 27.2%, including €3.27 m in margin relating to Sogec and Budgetbox businesses. Excluding these acquisitions in 2025, the businesses posted organic growth of 3.7% in Q3 2026 to €14.44 m like for like. The Retail Activation division (up 23.6% on a reported basis with Sogec and down 3% on a like-for-like basis excluding Sogec) declined slightly over the quarter, as expected, after the strong momentum in the first half. The development of the solutions HighCo Nifty (mobile coupons) and HighCo Merely (promotion management SaaS platform) is moving forward, and the number of e-coupons processed continues to rise. Businesses in the Retail Agencies division showed a decline over the quarter (down 3.3%). The gross profit of the Retail Media division posted growth, as expected (up 87.6% reported with Budgetbox and up 38.2% like for like excluding Budgetbox), as the historical in-store media selling businesses benefit from a favourable comparative base.

In the first nine months of 2026, business in France grew (up 31.5% reported, up 5.3% like for like), accounting for 92% of the Group’s reported gross profit.

Decline in International businesses

INTERNATIONAL	Gross Profit (€ m)		2026/2025 Change	% Total gross profit Reported
	2026	2025
Q1	1.75	2.19	-20.1%	8.8%
Q2	1.50	1.88	-19.8%	7.8%
Q3	1.45	1.72	-15.7%	7.5%
9-month total	4.70	5.78	-18.7%	8.0%

International businesses declined by 15.7% to €1.45 m in Q3 2026.

In Belgium, gross profit fell by 17.8% to €1.27 m given the continued significant decline in the activities of coupon processing and cashback programme management over the quarter.

Businesses in Spain showed growth of 2.6% and accounted for 0.9% of the Group’s reported gross profit.

For the first nine months of 2026, International businesses fell 18.7% to €4.7 m and account for 8% of the Group’s reported gross profit.

CSR STRATEGY: ECOVADIS GOLD MEDAL RENEWED

In September 2026, HighCo’s “Gold” medal was renewed by EcoVadis as recognition for its CSR performance and responsible purchasing, with an overall score of 85 out of 100 and a strong increase of 7 points. This detailed assessment measures the maturity of CSR policies and actions taken based on 21 criteria grouped into four themes: Environment, Labour and Human Rights, Ethics, and Sustainable Procurement. HighCo has therefore maintained its ranking in the top 5% of companies assessed by EcoVadis.

The Group continues its sustainability actions, with the development of its strategic roadmap to 2030: “Impact 2030”.

REFINED GUIDANCE FOR 2026

Based on the reported business performance in Q3, in line with forecasts, and the business levels expected for Q4, the Group has refined its guidance for 2026:

• Gross profit of more than €77 m including the acquisitions of Sogec and Budgetbox activities over the full year, for growth of more than 15% (reported 2025 gross profit: €66.65 m);
• Adjusted operating margin (adjusted headline PBIT/gross profit) of slightly more than 13% (2025 adjusted operating margin: 12.1%).

In the fourth quarter, the Group’s financial resources will mainly be allocated to restructuring Sogec’s businesses.

CONFIRMATION OF A SIGNIFICANT IMPROVEMENT IN PROFITABILITY AS OF 2027

As announced in September, the Group’s strategy to refocus its activities and transform its business, under way since 2025, will begin to pay off. As a result, HighCo expects a significant improvement in its profitability, with adjusted operating margin of more than 15% as of 2027.

About HighCo

HighCo is a marketing and communication expert that supports brands and retailers in implementing their promotion activations. Its unique operational model covers campaign design, delivery, processing and monitoring.
Listed in compartment C of Euronext Paris, and eligible for SME equity savings plans (“PEA-PME”), HighCo has more than 500 employees.
HighCo has achieved a Gold rating from EcoVadis, meaning that the Group is ranked in the top 5% of companies in terms of CSR performance and responsible purchasing.

Your contacts

Cécile Collina-Hue                Nicolas Cassar
Managing Director                Press Relations
+33 1 77 75 65 06                +33 4 88 71 35 46
comfi@highco.com                n.cassar@highco.com

Upcoming event

Publication takes place after market close.

Q4 2026 and FY 2026 Gross Profit: Wednesday, 27 January 2027

                

HighCo is a component stock of the indices CAC^® Small (CACS), CAC^® Mid&Small (CACMS), CAC^® All-Tradable (CACT), Euronext^® Tech Croissance (FRTPR) and Enternext^® PEA-PME 150 (ENPME).
ISIN: FR0000054231
Reuters: HIGH.PA
Bloomberg: HCO FP
For further financial information and press releases, go to www.highco.com.

This English translation is for the convenience of English-speaking readers. Consequently, the translation may not be relied upon to sustain any legal claim, nor should it be used as the basis of any legal opinion. HighCo expressly disclaims all liability for any inaccuracy herein.

Attachment

• HighCo CP T3_2026_FR_VDEF_EN

  

Turin, 21^st October 2026. Iveco Group N.V. (EXM: IVG) announces that Damiano Cretarola will assume the role of Chief Financial Officer (CFO) as of 2^nd November 2026. He succeeds Anna Tanganelli, who has served as CFO since December 2023. Mr Cretarola will join the Senior Leadership Team (SLT) and report directly to Olof Persson, CEO, Iveco Group.

Damiano Cretarola has been with Iveco Group since its inception in 2022 and has consistently held senior roles, most recently as Senior Vice President, Planning & Controlling. His career within the Group’s businesses began in 2004 and he has since held several senior finance roles, including regional and business Chief Financial Officer positions at CNH Global and CNH Industrial.

Within the Group he has gained extensive experience in the capital goods, commercial vehicles and automotive industries and a profound understanding of the Group’s operations. He brings broad expertise in financial planning and analysis, business controlling, accounting, risk management, international strategy, financial reporting and business transformation.

Before joining the Group, Mr Cretarola spent ten years at PricewaterhouseCoopers (PwC) in Switzerland, holding managerial positions of increasing responsibilities in Audit and Consulting.

Olof Persson, CEO, Iveco Group, commented: “I am truly pleased to welcome Damiano to the role of CFO. This reflects not only the pivotal contribution he has made in leading our finance organisation through periods of significant change, but also his deep understanding of Iveco Group’s business, financial dynamics and strategic priorities. I look forward with great confidence to continuing to work alongside him as a valued member of our Senior Leadership Team.”

Iveco Group N.V. (EXM: IVG) is a global player in the automotive industry, built on a strong Italian heritage and with a consolidated international reach. The Group channels decades of engineering excellence and innovation into sustainable mobility and customer driven technologies. Its five brands play a leading role in their respective domains: IVECO, a pioneering commercial vehicles brand offering heavy, medium and light duty trucks; FPT, a global leader in advanced powertrain technologies in the agriculture, construction, marine, power generation and commercial vehicles sectors; IVECO BUS and HEULIEZ, renowned for their mass transit, premium bus and coach solutions; and IVECO CAPITAL, the Group’s financing arm supporting them all. Iveco Group employs 33,000 people and operates 16 industrial sites and 22 R&D centres. Further information is available at www.ivecogroup.com.

Media Contacts:
Francesco Polsinelli, Tel: +39 335 1776091
Fabio Lepore, Tel: +39 335 7469007
E-mail: mediarelations@ivecogroup.com

Investor Relations:
Federico Donati, Tel: +39 011 0073539
E-mail: investor.relations@ivecogroup.com

Attachment

• 20261021_IVG_PR_Iveco_Group_Appoints_New_Chief_Financial_Officer

PRESS RELEASE | October 21st, 2026 – 5.45pm

Q3 2026 REVENUE

SYNERGIE continues its growth momentum in the third quarter of 2026 and reports revenue of €917.2 million, up 11.2% (+2.4% on a like-for-like basis)

in € m	Q3 2026	Q3 2025	Variation	9M 2026	9M 2025	Variation
International	601.2	505.1	+19.0%	1,688.9	1,462.6	15.5%
France	316.0	319.9	-1.2%	938.8	946.0	-0.8%
Total	917.2	825.0	+11.2%	2,627.7	2,408.6	+9.1%

SYNERGIE reported third-quarter 2026 revenue of €917.2 million, up 11.2% compared with the same period in 2025 (+2.4% on a like-for-like basis). For the first nine months of the year, revenue amounted to €2,627.7 million, representing a growth of 9.1% (+2.3% at constant scope and exchange rates). This increase is mainly due to the acquisitions completed in Switzerland and Canada. International operations now account for 64.3% of Group revenue, compared with 60.7% at the end of September 2025.

International revenue increased by +19.0% in the third quarter (+4.6% on a like-for-like basis). This performance includes a scope effect related to acquisitions, representing €70.6 million during the quarter, as well as the solid performance of the Group’s historical operations across several countries.

Southern Europe continued its growth momentum, with revenue increasing by +9.1% in the third quarter, confirming the strength of the Group’s positions in the region. In Northern and Eastern Europe, revenue rose by +11.3% (-1.0% on a like-for-like basis), supported by the integration of the Swiss operations acquired during the year, while on a like-for-like basis activity remained affected by a subdued economic environment. Outside Europe, revenue benefited from the integration of Agilus in Canada.

In France, revenue amounted to €316.0 million in the third quarter, broadly stable compared with the same period in 2025 (-1.2%). In an economic environment that remains complex, the Group’s operations continue to demonstrate resilience.

In an international environment marked by persistent economic and geopolitical uncertainties, SYNERGIE continues its development with both caution and determination. Supported by the resilience of its business model and the diversification of its activities, the Group remains confident in its ability to sustain its growth trajectory.

NEXT EVENT

• Publication of 2026 Revenue on January 27th, 2026, after market closing

Attachment

• Press_Release_CA_Q3_2026_ENG_VDEF

EXHIBIT (a)(5)(A) 

NEWS RELEASE ANNOUNCING TENDER OFFERS 

LUXEMBOURG, Oct. 21, 2026 (GLOBE NEWSWIRE) — BrightFlixx Finance (Luxembourg) S.A., a Luxembourg public limited company (société anonyme) (the “Purchaser”), today announced that it has commenced two concurrent cash tender offers. In the first offer, the Purchaser is offering to purchase all outstanding shares of common stock (the “CVAT Shares”) of Cavitation Technologies, Inc., a Nevada corporation (the “Company”). In the second offer, the Purchaser is offering to purchase all outstanding shares of common stock (the “ABI Shares”) of Alchemy Beverages Inc., a privately held Delaware corporation affiliated with the Company (“Alchemy”).

SHAREHOLDER INFORMATION WEBSITE: https://brightflixx.capital/

CAVITATION TECHNOLOGIES, INC. — THE OFFER

Final Offer Price and Record Date

Under the tender offer for CVAT Shares (the “CVAT Offer”), the final offer price per share (the “Final Offer Price”) will equal (a) a net aggregate purchase price of $35,000,000, less the outstanding liabilities of the Company on the Record Date, divided by (b) the total number of CVAT Shares outstanding on the Record Date. The Record Date for determining the Final Offer Price is December 24, 2026.

Based on recent information reported by the Company, showing outstanding liabilities of approximately $738,000 and 332,820,459 CVAT Shares outstanding as of October 16, 2026, the initial undiluted estimated price would be approximately $0.105 per share. The Final Offer Price will be calculated using the actual number of outstanding CVAT Shares and the Company’s outstanding liabilities existing at the close of the Record Date.

Key Timelines and Extensions

Offer Commencement Date: October 20, 2026.

Record Date: December 24, 2026, which is 45 business days after commencement of the CVAT Offer.

Offer Extension: The initial period of the CVAT Offer consists of 65 business days from and after commencement and is scheduled to expire at 11:59 p.m., Pacific Time or Pacific Daylight Time, as applicable, on January 26, 2027 (the “Expiration Time”). After the Final Offer Price is announced following the Record Date, the Expiration Time will be extended as necessary to provide shareholders at least 30 business days to review the Final Offer Price and decide whether to tender their CVAT Shares.

Key Conditions to the Offer

The CVAT Offer is subject to the satisfaction or waiver of the conditions set forth in the Tender Offer Agreement dated October 9, 2026 between the Purchaser and the Company (the “BF-CVAT Agreement”). The most significant conditions include:

Minimum Tender. A sufficient number of CVAT Shares must be validly tendered to enable the Purchaser to acquire at least 90% of the Company’s outstanding common stock.

Concurrent Alchemy Offer. The conditions to the Purchaser’s concurrent tender offer for Alchemy must be satisfied or waived, and sufficient ABI Shares must be validly tendered to enable the Purchaser to acquire or own at least 90% of Alchemy’s outstanding common stock.

Compliance. The Company must be in compliance with its representations, warranties, and covenants under the BF CVAT Agreement, subject to the materiality standards specified in that agreement.

No Material Adverse Effect. No material adverse effect may have occurred with respect to the Company’s business or financial condition.
Regulatory Approval. The transaction must be reviewed and cleared by the Committee on Foreign Investment in the United States (CFIUS), and no governmental entity may have taken adverse action to block or prevent the acquisition of tendered CVAT Shares.

Delivery of Shares; Payment Services

Shareholders may tender CVAT Shares by delivering physical stock certificates or using book-entry procedures to transfer their shares to Dynamic Stock Transfer, Inc., the designated depositary and paying agent. Dynamic Stock Transfer will receive tendered CVAT Shares, process tender acceptances, and distribute payment for CVAT Shares accepted and purchased by the Purchaser.

ALCHEMY BEVERAGES INC. — THE OFFER

Final Offer Price and Record Date

Under the tender offer for ABI Shares (the “ABI Offer”), the final offer price per share will equal (a) a net aggregate purchase price of $7,000,000, less Alchemy’s outstanding liabilities on the Record Date, divided by (b) the total number of ABI Shares outstanding on the Record Date. The Record Date for determining the final offer price is December 24, 2026.

Based on recent information reported by Alchemy, showing outstanding liabilities of approximately $88,441.81 and 18,798,473 ABI Shares outstanding as of October 16, 2026, the initial undiluted estimated price would be approximately $0.368 per share. The final offer price will be calculated using the actual number of outstanding ABI Shares and Alchemy’s outstanding liabilities existing at the close of the Record Date.

Key Timelines and Extensions

The ABI Offer commenced on October 20, 2026. The Record Date is December 24, 2026. The initial offer period consists of 65 business days after commencement and is scheduled to expire at 11:59 p.m., Pacific Time or Pacific Daylight Time, as applicable, on January 26, 2027. After the Final Offer Price is announced, the Expiration Time will be extended as necessary to provide shareholders at least 30 business days to review the Final Offer Price and decide whether to tender their ABI Shares.

Key Conditions to the ABI Offer

The ABI Offer is subject to the satisfaction or waiver of the conditions set forth in the Tender Offer Agreement dated October 9, 2026 between the Purchaser and Alchemy (the “BF-ABI Agreement”). The most significant conditions include:

Minimum Tender. A sufficient number of ABI Shares must be validly tendered to enable the Purchaser to acquire at least 90% of Alchemy’s outstanding common stock.

Concurrent CVAT Offer. The conditions to the Purchaser’s concurrent tender offer for the Company must be satisfied or waived, and sufficient CVAT Shares must be validly tendered to enable the Purchaser to acquire or own at least 90% of the Company’s outstanding common stock.

Compliance. Alchemy must be in compliance with its representations, warranties, and covenants under the BF-ABI Agreement, subject to the materiality standards specified in that agreement.

No Material Adverse Effect. No material adverse effect may have occurred with respect to Alchemy’s business or financial condition.

Regulatory Approval. The transaction must be reviewed by CFIUS, and no governmental entity may have taken adverse action to block or prevent the acquisition of tendered ABI Shares.

Fairness Opinion

Because Alchemy is privately held and its shares are not listed on a national securities exchange or OTC Markets platform, Alchemy will, pursuant to the BF-ABI Agreement, obtain a fairness opinion from a qualified independent third party regarding the current market value of Alchemy and its capital stock. The fairness opinion may not be used to reduce the final offer price determined following the Record Date, but, depending on the value assigned to Alchemy, may provide a basis for an upward adjustment in the final market price under the ABI Offer and the CVAT Offer.
Delivery and Payment Services

Shareholders may tender ABI Shares by delivering physical stock certificates or using book-entry transfer procedures to transfer their shares to Dynamic Stock Transfer, Inc., the designated depositary and paying agent responsible for processing tender acceptances and distributing payment for ABI Shares accepted and purchased by the Purchaser.

Additional Information and Where to Find It

This press release is for informational purposes only. It is neither an offer to purchase nor a solicitation of an offer to sell shares under either tender offer. The solicitation and offer to buy CVAT Shares are being made only pursuant to the CVAT Offer to Purchase, the CVAT Letter of Transmittal, and related materials filed with the U.S. Securities and Exchange Commission (the “SEC”) on Schedule TO-T. The solicitation and offer to buy ABI Shares are being made
only pursuant to the ABI Offer to Purchase, the ABI Letter of Transmittal, and related materials filed with the SEC in the same Schedule TO-T filing, as amended or supplemented.

Shareholders may review the current public tender-offer materials, SEC filing package, Offer to Purchase documents, Letters of Transmittal, broker and client communications, transaction agreements, and related notices at the BrightFlixx shareholder information website: https://brightflixx.capital/. The website is provided for information only. It does not accept tenders, share certificates, account information, payment instructions, or other tender submissions. Shareholders should follow only the instructions contained in the final tender-offer materials and should consult their own financial, tax, and legal advisers.

Copies of the tender-offer documents may also be obtained free of charge from the SEC’s website, from the Purchaser or the Company, or directly from Dynamic Stock Transfer, Inc., 3347 Cerritos Avenue, Los Alamitos, California 90720, telephone +1 (213) 667-0197.

Forward-Looking Statements

This press release contains forward-looking statements regarding the expected timing, value, and completion of the cash tender offer for CVAT Shares and the concurrent cash tender offer for ABI Shares. Actual results may differ materially because of risks and uncertainties, including whether the conditions to either offer will be satisfied or waived, whether a sufficient number of shares will be tendered to satisfy the 90% minimum condition, whether required regulatory reviews will be completed, and whether the transactions will be consummated in a timely manner or at all. The Purchaser undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

About BrightFlixx Finance (Luxembourg) S.A.

BrightFlixx Finance (Luxembourg) S.A. is a Luxembourg public limited company (société anonyme) qualified as a securitization company under the Luxembourg Securitization Law. BrightFlixx focuses on strategic international investments, corporate asset optimization, and specialized securitization solutions for affiliates and investor portfolios.

Investor and Media Contact

BrightFlixx Finance (Luxembourg) S.A.

Shareholder information website:

https://brightflixx.capital/

CONTACT: office@brightflixxfinance.com

Ivry-sur Seine, October 21, 2026, 5:45 p.m. CET

LFL¹ REVENUE UP +1.8% IN Q3 2026 AND +1.1% IN 9M 2026
GROSS MARGIN RATE INCREASE (+40 bps)
OUTLOOK CONFIRMED

MERGER CONTROL CLEARANCE FROM THE EUROPEAN COMMISSION OBTAINED
TAKEOVER BID TO CLOSE ON NOVEMBER 9, 2026

• 9M 2026 revenue of €6,966 million, up +1.1% LFL¹ compared with 9M 2025²
• 9M online sales up +5.3%, with Click & Collect accounting for close to 50% of online sales
• Gross margin rate up 40 bps compared with 9M 2025²
• 2026 outlook confirmed
• Takeover bid by EP Group:
  • Merger control clearance from the European Commission obtained
  • Offer period closing on November 9, 2026
  • If successful, the Offer should be reopened for at least ten trading days

Enrique Martinez, Chief Executive Officer of Fnac Darty, declared: “Our group is performing very strongly in a complex context, as illustrated by the events of the last few days in France. I would like to thank our teams who have shown exemplary professionalism and commitment in the stores that have been affected by theft and violence. We are determined to quickly restore these stores to be able to welcome our customers again in the best conditions. We are pleased that EP Group’s public takeover bid has obtained the required clearance from the European Commission and can now move forward to completion. Our shareholders have until November 9 to tender their shares.“

KEY FIGURES AT THE END OF SEPTEMBER 2026

	Q3 2026			9M 2026
(€ million)	2025 reported	2025 restated2	2026	2025 reported	2025 restated2	2026
Revenue	2,488.3	2,460.7	2,508.6	6,968.1	6,884.0	6,965.7
Change vs 2025 restated			+1.9%			+1.2%
LFL change1			+1.8%			+1.1%

In Q3 2026, Group revenue amounted to €2,509 million, up +1.8% on a like-for-like basis¹ compared with Q3 2025². France was almost stable at -0.4% LFL¹. The Rest of Europe posted strong growth (+5.0% LFL¹).

At the end of September 2026, revenue was €6,966 million, up +1.1% on a like-for-like basis¹ compared with 9M 2025².

Gross margin rate has increased by 40 bps compared with 9M 2025 restated², primarily due to the growing contribution of services businesses and a favorable product mix.

CHANGES BY DISTRIBUTION CHANNEL

At the end of September 2026, in-store sales were stable. Conversely, online sales increased (+5.3% compared with 9M 2025²) and represented more than 21% of the Group’s total sales, driven in particular by the Group’s marketplaces (direct and reverse). Omnichannel sales (Click & Collect) increased compared with 9M 2025² and represented close to 50% of the Group’s online revenue. These results confirm, once again, the relevance of the omnichannel strategy adopted by Fnac Darty.

CHANGE BY PRODUCT CATEGORY AT THE END OF SEPTEMBER

Domestic appliances posted solid growth, driven by small domestic appliances, particularly floor care, coffee and seasonal products. Large domestic appliances also grew, benefiting from the good performance of air conditioning and refrigeration products in favorable weather conditions.

Consumer electronics recorded slight growth, with contrasting trends across categories. Hardware sales continued to benefit from the end of support for Windows 10 and the ongoing replacement cycle. Telephony sales grew, driven by a good third quarter, while sound, photo and television were slightly down.

Diversification posted mid-single-digit growth, driven in particular by double-digit growth in toys & games.

Services continued to grow, supported by strong momentum in subscription-based offers.

Lastly, editorial products declined, penalized by an unfavorable comparison base in gaming following the successful launch of the Switch 2 in 2025. Books were down in a market with few notable new releases, while audio remained very dynamic thanks to vinyl.

CHANGE BY GEOGRAPHY AT THE END OF SEPTEMBER

France posted a -0.6% decline in LFL¹ revenue compared with 9M 2025². Although weather conditions supported certain categories, activity remained affected by a subdued consumer environment.

Rest of Europe posted an increase in LFL¹ revenue of +3.5% compared with 9M 2025²:

• Italy posted LFL¹ growth of +2.5% across all distribution channels.
• Belgium-Luxembourg recorded LFL¹ growth of +5.2%, driven by strong consumption momentum.
• Portugal posted LFL¹ growth of +8.0%, driven by strong momentum across both brands and all distribution channels. The acquisition of 11 Staples stores will strengthen the brand’s territorial footprint in 2027.
• Spain posted LFL¹ growth of +4.4%, supported by positive momentum across all categories, both in stores and online. Renovated stores performed well.
• Switzerland was down -1.1% LFL¹, mainly impacted by the decline in the book and hardware markets.

UNIEURO

The integration of Unieuro is progressing in line with the announced timetable. The French and Italian teams are working together to deploy the strategic initiatives of the Beyond everyday plan. Operating performance in Italy is satisfactory. The Group confirms its target of at least €20 million in synergies by the end of 2026.

REPAIR & BEYOND

For the ninth consecutive year, Fnac Darty is presenting the results of its after-sales services barometer, which outlines the major durability trends observed in the field. Reported at the beginning of October, it provides objective and independent insight into product reliability and repairability. This new edition notably highlights the solutions available in the event of breakdowns and the expertise of the entire repair sector in dealing with increasingly complex products.

BEYOND DIGITIZED OMNICHANNEL

Opened on October 6, the new Fnac store in Toulouse illustrates the evolution of the brand’s model: smoother customer journeys, enhanced services, modular spaces and personalized support. Designed to adapt to key trading periods and host new events and experiences, it brings together all Fnac product categories, complemented by a Darty corner dedicated to small domestic appliances, a WeFix area for smartphone and tablet repairs, and a Lego shop-in-shop. This new concept reflects the ambitions of Beyond everyday: simplifying the customer experience, strengthening the complementarity between stores, e-commerce, services and repair, and enhancing proximity and expertise.

BEYOND RETAIL

Retailink by Fnac Darty continued to roll out its XXL DOOH offering with a new display at Fnac La Défense, inaugurated this summer, bringing its network of large-format displays in Paris and Nice to six. This expansion is in line with the Group’s strategy to digitize its points of sale and reinforces the ambition of the Group’s retail media agency to offer the most comprehensive premium DOOH Retail Media solution in the French market.

EP GROUP’S TAKEOVER BID FOR FNAC DARTY

Fnac Darty and EP FR HOLDCo, the vehicle controlled by EP Group and established for the purposes of the proposed public tender Offer for the outstanding shares and OCEANEs of Fnac Darty announced on October 20, 2026 that they had received the merger control clearance from the European Commission for the planned acquisition of Fnac Darty.

As a result of the receipt of this decision, which constitutes the last expected approval of the transaction, the French Financial Markets Authority (Autorité des marchés financiers, “AMF”) announced on October 20, 2026 that the Offer for Fnac Darty securities will close on November 9, 2026.

Fnac Darty shareholders and OCEANE holders therefore have until November 9, 2026 to tender their securities to the EP FR HOLDCo Offer.

The Offer price is €35 per share, following the payment on June 5, 2026 of a dividend of €1 per share in respect of the 2025 financial year, and €81.16³ per OCEANE.

The AMF is expected to publish the Offer results notice in the days following November 9, 2026.

The settlement will take place on November 12, 2026.

If successful, the Offer will be reopened for at least ten trading days.

Documentation relating to the Offer is available on Fnac Darty’s website in the section dedicated to the Offer (www.fnacdarty.com/le-groupe/investisseurs/projet-doffre-publique-dachat-de-ep-group/) and on the AMF website (www.amf-france.org).

OUTLOOK

The Group confirms its expectation of an increase in its 2026 current operating margin rate and free cash flow from operations.
Fnac Darty is continuing to implement the strategic roadmap of the Beyond everyday plan, presented on June 11, 2025, and confirms the objectives communicated for 2030.

*********

Q3 2026 REVENUE

Enrique Martinez, Chief Executive Officer and Jean-Brieuc Le Tinier, Group Chief Financial Officer, will host a virtual presentation in French, with simultaneous interpretation into English.

Wednesday, October 21, 2026, at 6:00 p.m. (Central European Time)
5:00 p.m. (UK) – 12:00 p.m. (East Coast USA)

The presentation will be streamed live at this link.

To join the conference call to listen by phone and ask questions:
France: +33 1 70 91 87 04
UK: +44 1 212 818 004
USA: +1 718 705 8796

You can listen to a recording of the presentation at any time, in either French or English, via the website www.fnacdarty.com.

CONTACTS
ANALYSTS/INVESTORS
Domitille Vielle – Head of Investor Relations – domitille.vielle@fnacdarty.com – +33 (0)6 03 86 05 02
Laura Parisot – Investor Relations Manager – laura.parisot@fnacdarty.com – +33 (0)6 64 74 27 18

PRESS
Bénédicte Debusschère – Head of Corporate Communications – benedicte.debusschere@fnacdarty.com – +33 (0)6 48 56 70 71

APPENDIX

The following tables contain individually rounded data. The arithmetical calculations based on rounded data may present some differences with the aggregates or subtotals reported.

REVENUE

in €m	Q3 2025 reported	Q3 2025 restated4	Q3 2026	Change compared with Q3 2025 restated
				Reported	LFL5
France	1,469.4	1,441.9	1,439.6	(0.2)%	(0.4)%
Rest of Europe	1,018.9	1,018.9	1,069.0	+4.9%	+5.0%
o/w Italy	617.0	617.0	643.0	+4.2%	+5.0%
o/w Belgium	159.8	159.8	166.4	+4.1%	+4.1%
o/w Portugal	130.5	130.5	135.7	+4.0%	+6.3%
o/w Spain	63.8	63.8	74.5	+16.8%	+9.6%
o/w Switzerland	47.8	47.8	49.5	+3.6%	+0.3%
Group	2,488.3	2,460.7	2,508.6	+1.9%	+1.8%

in €m	9M 2025 reported		9M 2025 restated1		9M 2026		Change compared with 9M 2025 restated
							Reported		LFL2
France	4,119.9		4,035.8		4,018.5		(0.4)%		(0.6)%
Rest of Europe	2,848.1		2,848.1		2,947.2		+3.5%		+3.5%
o/w Italy	1,737.4		1,737.4		1,777.0		+2.3%		+2.5%
o/w Belgium	439.5		439.5		462.1		+5.1%		+5.2%
o/w Portugal	344.6		344.6		364.1		+5.7%		+8.0%
o/w Spain	192.1		192.1		207.4		+8.0%		+4.4%
o/w Switzerland	134.6		134.6		136.6		+1.5%		(1.1)%
Group	6,968.1		6,884.0		6,965.7		+1.2%		+1.1%

2025 RESTATED1	Q1	Q2	H1	Q3	9M	Q4	H2	FY
in €m
France	1,343.7	1,250.2	2,593.9	1,441.9	4,035.8	2,033.1	3,474.9	6,068.9
Rest of Europe	942.1	887.2	1,829.3	1,018.9	2,848.1	1,412.8	2,431.7	4,260.9
o/w Italy	573.2	547.2	1,120.4	617.0	1737.4	846.4	1,463.3	2,583.7
o/w Belgium	153.0	126.7	279.7	159.8	439.5	191.7	351.5	631.2
o/w Portugal	104.4	109.7	214.1	130.5	344.6	194.4	324.9	539.0
o/w Spain	67.0	61.2	128.3	63.8	192.1	103.5	167.3	295.6
o/w Switzerland	44.4	42.4	86.8	47.8	134.6	76.8	124.6	211.4
Group	2,285.8	2,137.4	4,423.2	2,460.7	6,884.0	3,445.9	5,906.6	10,329.8

STORE NETWORK

	December 31, 2025			September 30, 2026
	Integrated	Franchises	Total	Integrated	Franchises	Total
France1	395	401	796	398	380	778
Rest of Europe	439	249	688	434	241	675
Italy	269	242	511	264	234	498
Belgium	84	–	84	84	–	84
Portugal	45	4	49	46	4	50
Spain	33	3	36	31	3	34
Switzerland	8	–	8	9	–	9
Total Group	834	650	1,484	832	621	1,453

¹ Including 15 stores abroad (3 in Qatar, 6 in Tunisia, 2 in Senegal, 2 in Ivory Coast, 1 in Congo and 1 in Cameroon), 14 stores in the French overseas territories, as well as Nature & Découvertes subsidiaries managed from France.

DEFINITIONS OF ALTERNATIVE PERFORMANCE INDICATORS

Revenue	The Group’s “real” revenue (or income from ordinary activities) corresponds to its reported revenue. The Group uses the notions of change in revenue detailed below.
Current operating income	Fnac Darty uses current operating income as the main management balance. This is defined as the difference between the total operating income and the “Other non-current operating income and expense.” Current operating income is an intermediate line item intended to facilitate the understanding of the entity’s operating performance that can be used as a way to estimate recurring performance. This indicator is presented in a manner that is consistent and stable over the long term in order to ensure the continuity and relevance of financial information.
Change in revenue at a constant exchange rate	Change in revenue at a constant exchange rate means that the impact of changes in exchange rates has been excluded. The exchange rate impact is eliminated by recalculating sales for period N-1 using the exchange rates used for period N.
Change in revenue on a like-for-like basis	Change in revenue on a like-for-like basis means that the impact of changes in the scope of consolidation is corrected so as to exclude the modifications (acquisition, disposal of subsidiary). Revenue of subsidiaries acquired or sold since January 1 of period N-1 are, therefore, excluded when calculating the change (in the event of a significant variation at Group level).
Change in revenue on a same-store basis	The change in revenue on a same-store basis means that the impact of directly owned store openings and closures is excluded. Revenue of stores opened or closed since January 1 of period N-1 is excluded from calculations of the change.

---

1 Like-for-like basis – LFL: excludes currency effects, changes in scope, store openings and closures.
2 Restated data: include the IFRS 5 reclassification of Nature & Découvertes as shown in the IFRS 2025 consolidated financial statements.

3 Calculated on the basis of an interest accrual period from 23 March 2026 to 12 November 2026, being the settlement date of the initial acceptance period of the Offer.
4 Restated data: include the IFRS 5 reclassification of Nature & Découvertes as shown in the IFRS 2025 consolidated financial statements.
5 Like-for-like basis – LFL: excludes the effect of changes in foreign exchange rates, changes in scope, and store openings and closures.

Attachment

• 20261021_Fnac_Darty_PR_Q32026_mel

SASKATOON, Saskatchewan, Oct. 21, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, announced today that senior management will present at the Planet MicroCap Toronto 2026 Conference (the “Conference”) at the Arcadian Loft in Toronto on Wednesday, October 28, 2026, at 5:30 P.M. Eastern Time.

Management will also be available to host in-person meetings with registered attendees during the Conference on October 28th and October 29th.

Interested parties can view the live and archived webcast of PharmaCorp’s presentation via the following webcast link:

https://event.summitcast.com/view/iiVo9HYfz9sL9CC5m4Dgpv/QPMMexbgA5BhuGZtkJGs6p

About PharmaCorp Rx Inc.

PharmaCorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. Through a combination of capital, strategic support and operational expertise, PharmaCorp is building a national network of community pharmacies under the PharmaChoice Canada banner.

As of the date of this news release, PharmaCorp operates 17 PharmaChoice Canada-bannered pharmacies and intends to continue acquiring both PharmaChoice Canada-bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform in accordance with its strategic alliance with PharmaChoice Canada, where applicable. PharmaCorp shares trade on the TSX Venture Exchange under the symbol PCRX.

PharmaCorp welcomes discussions with pharmacy owners considering succession or sale. For more information about PharmaCorp’s acquisition program and process, please visit www.PharmaCorpRx.ca or contact our team confidentially. PharmaCorp is committed to seamless transitions that protect pharmacy owners’ legacies and continue serving their communities.

For further information, please contact:

Investor Relations
LodeRock Advisors Inc.
Adam Peeler
adam.peeler@pharmacorprx.ca
Tel: (416) 427-1235

Alan Simpson, Executive Chair
Tel: (306) 536-3771

Neither the TSX Venture Exchange nor its Regulation Services Provider, as that term is defined in the policies of the TSX Venture Exchange, accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

This news release contains “forward-looking information” regarding the Corporation within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information.

In particular, this news release contains forward-looking information relating to: the Corporation’s participation in the Conference, including the date and time of its presentation and the availability of management for in-person meetings; the availability of a live and archived webcast of the presentation; the Corporation’s focus on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners; the Corporation’s strategy of building a national network of community pharmacies under the PharmaChoice Canada banner through a combination of capital, strategic support and operational expertise; and the Corporation’s intention to continue acquiring PharmaChoice Canada-bannered and independent pharmacies across Canada and to rebrand non-bannered locations under the PharmaChoice Canada platform, where applicable.

This forward-looking information reflects current beliefs and is based on information currently available to the management of the Corporation and on assumptions the Corporation believes are reasonable. These assumptions include, but are not limited to: the Conference proceeding as scheduled; the availability of management to present and attend meetings at the Conference; the ongoing interest from independent pharmacy owners considering succession options; the continued availability of pharmacies for purchase by the Corporation at prices satisfactory to the Corporation; the availability of financing on acceptable terms; and the volume of acquisition opportunities presented to the Corporation being equal to or greater than historical volumes.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: the postponement, rescheduling or cancellation of the Conference or the Corporation’s presentation; technical difficulties affecting the webcast; general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delays or failures to receive board of directors, third-party or regulatory approvals; competition; changes in legislation, including pharmacy regulation, affecting the Corporation; the timing and availability of external financing on acceptable terms; conclusions of economic evaluations and appraisals; and a lack of qualified, skilled labour or the loss of key individuals.

A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Corporation’s disclosure documents on the SEDAR+ website at www.sedarplus.ca. Although the Corporation has attempted to identify important risks and factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.

Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which it is based will occur.

The forward-looking information contained in this news release is expressly qualified by this cautionary statement and represents the expectations of the Corporation as of the date of this news release. Accordingly, it is subject to change after such date. The Corporation expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SASKATOON, Saskatchewan, Oct. 21, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, announced today that senior management will present at the Planet MicroCap Toronto 2026 Conference (the “Conference”) at the Arcadian Loft in Toronto on Wednesday, October 28, 2026, at 5:30 P.M. Eastern Time.

Management will also be available to host in-person meetings with registered attendees during the Conference on October 28th and October 29th.

Interested parties can view the live and archived webcast of PharmaCorp’s presentation via the following webcast link:

https://event.summitcast.com/view/iiVo9HYfz9sL9CC5m4Dgpv/QPMMexbgA5BhuGZtkJGs6p

About PharmaCorp Rx Inc.

PharmaCorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. Through a combination of capital, strategic support and operational expertise, PharmaCorp is building a national network of community pharmacies under the PharmaChoice Canada banner.

As of the date of this news release, PharmaCorp operates 17 PharmaChoice Canada-bannered pharmacies and intends to continue acquiring both PharmaChoice Canada-bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform in accordance with its strategic alliance with PharmaChoice Canada, where applicable. PharmaCorp shares trade on the TSX Venture Exchange under the symbol PCRX.

PharmaCorp welcomes discussions with pharmacy owners considering succession or sale. For more information about PharmaCorp’s acquisition program and process, please visit www.PharmaCorpRx.ca or contact our team confidentially. PharmaCorp is committed to seamless transitions that protect pharmacy owners’ legacies and continue serving their communities.

For further information, please contact:

Investor Relations
LodeRock Advisors Inc.
Adam Peeler
adam.peeler@pharmacorprx.ca
Tel: (416) 427-1235

Alan Simpson, Executive Chair
Tel: (306) 536-3771

Neither the TSX Venture Exchange nor its Regulation Services Provider, as that term is defined in the policies of the TSX Venture Exchange, accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

This news release contains “forward-looking information” regarding the Corporation within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information.

In particular, this news release contains forward-looking information relating to: the Corporation’s participation in the Conference, including the date and time of its presentation and the availability of management for in-person meetings; the availability of a live and archived webcast of the presentation; the Corporation’s focus on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners; the Corporation’s strategy of building a national network of community pharmacies under the PharmaChoice Canada banner through a combination of capital, strategic support and operational expertise; and the Corporation’s intention to continue acquiring PharmaChoice Canada-bannered and independent pharmacies across Canada and to rebrand non-bannered locations under the PharmaChoice Canada platform, where applicable.

This forward-looking information reflects current beliefs and is based on information currently available to the management of the Corporation and on assumptions the Corporation believes are reasonable. These assumptions include, but are not limited to: the Conference proceeding as scheduled; the availability of management to present and attend meetings at the Conference; the ongoing interest from independent pharmacy owners considering succession options; the continued availability of pharmacies for purchase by the Corporation at prices satisfactory to the Corporation; the availability of financing on acceptable terms; and the volume of acquisition opportunities presented to the Corporation being equal to or greater than historical volumes.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: the postponement, rescheduling or cancellation of the Conference or the Corporation’s presentation; technical difficulties affecting the webcast; general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delays or failures to receive board of directors, third-party or regulatory approvals; competition; changes in legislation, including pharmacy regulation, affecting the Corporation; the timing and availability of external financing on acceptable terms; conclusions of economic evaluations and appraisals; and a lack of qualified, skilled labour or the loss of key individuals.

A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Corporation’s disclosure documents on the SEDAR+ website at www.sedarplus.ca. Although the Corporation has attempted to identify important risks and factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.

Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which it is based will occur.

The forward-looking information contained in this news release is expressly qualified by this cautionary statement and represents the expectations of the Corporation as of the date of this news release. Accordingly, it is subject to change after such date. The Corporation expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

Series	RIKS 37 0115	RIKS 50 0915
ISIN	IS0000033793	IS0000037794
Maturity Date	01/15/2037	09/15/2050
Auction Date	10/23/2026	10/23/2026
Settlement Date	10/28/2026	10/28/2026
10% addition	10/27/2026	10/27/2026

On the Auction Date, between 10:30 am and 11:00 am, the Government Debt Management will auction Treasury bonds in the Series, with the ISIN numbers and with the Maturity Dates according to the table above. Payments for the Treasury bonds must be received by the Central Bank before 14:00 on the Settlement Date, and the Bonds will be delivered in electronic form on the same day. Article 6 of the General Terms of Auction for Treasury bonds applies for the right to purchase an additional 10%.

Further reference is made to the description of the Treasury bond and the General Terms of Auction for Treasury bonds on the Government Debt Management website.

For additional information please contact Magnús Freyr Hrafnsson, Government Debt Management, at +354 569 9679.